Month: June 2023

LOS ANGELES, June 23, 2023 (GLOBE NEWSWIRE) — (NASDAQ: ENOB). Enochian BioSciences Inc., a company developing gene-modified cell immunotherapies for cancer and infectious diseases, wishes to advise that its 2023 Annual Stockholder Meeting (the “Annual Meeting”), which was scheduled to be held yesterday, June 22, 2023 at 12:00 p.m. Eastern Time, was convened and adjourned, without any business being conducted, due to the lack of the required quorum. As a result of the required quorum not being present, the Annual Meeting has been adjourned to 12:00 p.m. (Eastern Time) on Friday July 21, 2023 (“Adjourned Annual Meeting”) to allow additional time for the Company’s stockholders to vote on the proposals set forth in the Company’s definitive proxy statement filed with the United States Securities and Exchange Commission (“SEC”) on May...

TORONTO, June 23, 2023 (GLOBE NEWSWIRE) — Euro Sun Mining Inc., (TSX: ESM) (“Euro Sun” or the “Company”) announces the resignation of Scott Moore as a member of the board of directors effective immediately. Management and the board of directors of the Company would like to thank Mr. Moore for his services and continued support of the Company. About Euro Sun Mining Inc. Euro Sun is a Toronto Stock Exchange listed mining company focused on the exploration and development of its 100%-owned Rovina Valley gold and copper project located in west-central Romania, which hosts the second largest gold deposit in Europe. Further information: For further information about Euro Sun Mining, or the contents of this press release, please contact Investor Relations at info@eurosunmining.com This press release contains “forward-looking information”...

GUELPH, Ontario, June 23, 2023 (GLOBE NEWSWIRE) — Current Water Technologies Inc. (TSX-V: WATR) (“CWTI” or “the Company” or “the Corporation”), is pleased to announce the signing of the Definitive Sales and Marketing Joint-Venture Agreement with ecoX Global Pte. Ltd. (formerly Separtis Technologies Global Pte Ltd) of Singapore. The joint-venture company is being incorporated in Singapore under the name WATR-H2 Pte. Ltd. CWTI is an emerging technology leader in the production of “GREEN HYDROGEN” from ammonia-contaminated wastewater, in the management of ammonia in industrial and municipal wastewaters and AQUACULTURE process and wastewater streams, and in the production of HIGH PURITY WATER for the boiler feedwater, pharmaceutical and micro-electronics sectors. CWTI’s CEO, Dr. Gene Shelp reports...

John F. Kennedy (CVN 79) HII’s Newport News Shipbuilding (NNS) division has received contract modifications from the U.S. Navy to shift the delivery strategy for the aircraft carrier John F. Kennedy (CVN 79). The contract action revises the delivery approach for the second Gerald R. Ford-class aircraft carrier, shifting work previously planned for post-delivery completion at NNS into the baseline contract. (Photo by Lexi Whitehead/HII).NEWPORT NEWS, Va., June 23, 2023 (GLOBE NEWSWIRE) — HII (NYSE: HII) announced today that its Newport News Shipbuilding (NNS) division has received contract modifications totaling $393.3 million from the U.S. Navy to shift the delivery strategy for the aircraft carrier John F. Kennedy (CVN 79). The contract action announced today revises the delivery approach for the second Gerald R. Ford-class...

WINNIPEG, Manitoba, June 23, 2023 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF), (the “Company” or “Kane Biotech”), today announces that it has issued 9,703,809 restricted share units of the Company (“RSUs”) to various directors, officers, employees and consultants of the Company pursuant to the second amended and restated performance and restricted share unit plan of the Company dated May 23, 2023. Each RSU is exercisable into one common share of the Company. The RSUs will vest at different times, but none will vest earlier than 12 months from the date of grant. About Kane Biotech Kane Biotech is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies, intellectual property...

NEW YORK, June 23, 2023 (GLOBE NEWSWIRE) — Nasdaq, Inc. (Nasdaq: NDAQ) today announced the Nasdaq Closing Cross was used for the 20th consecutive year to rebalance Nasdaq-listed securities in the entire family of Russell US Indexes, part of leading global index provider FTSE Russell, during its annual reconstitution. Approximately 2.55 billion shares representing $61.7 billion were executed in the Nasdaq Closing Cross in 0.86 seconds across Nasdaq-listed securities. “Today represents twenty years of partnership between Nasdaq and FTSE Russell in the annual Russell Rebalance,” said Kevin Kennedy, Executive Vice President of North American Trading Services at Nasdaq. “Over the past twenty years we have facilitated the crossing of hundreds of billions of dollars across thousands of symbols. Nasdaq is proud that our transparent...

TORONTO, June 23, 2023 (GLOBE NEWSWIRE) — Firm Capital Property Trust (“FCPT” or the “Trust“), (TSX: FCD.UN) is pleased to announce the voting results from its Annual Meeting of unitholders (“Unitholders”) of Trust Units (“Units”) of the Trust held on June 23, 2023 (the “Meeting”). All the matters put forward before Unitholders for consideration and approval as set out in the Trust’s management information circular dated May 9, 2023 (the “Circular“) were approved by the requisite majority of votes cast at the Meeting. In particular, Unitholders approved the election of all trustee nominees and the approval of RSM Canada LLP as the Trust’s auditors. The board of trustees of the Trust is now comprised as follows:Nominee Votes “For” % Votes “For” Votes...

Press Release­­­­­­­ No. 5 / 2023 Data shows nearly 19% weight loss in people with overweight or obesity in Boehringer Ingelheim and Zealand Pharma Phase II trial with survodutide (BI 456906)1Up to 40% of people who reached the highest two doses of survodutide (BI 456906) achieved a weight loss of at least 20%1 Survodutide has a novel mechanism of action (agonism of the dual GCG/GLP-1 receptors) that may have direct effects on energy expenditure in the liver in addition to decreasing appetite2 Detailed data were presented at the 2023 American Diabetes Association’s 83rd Scientific SessionsIngelheim, Germany, and Copenhagen, Denmark, 23 June, 2023 – Boehringer Ingelheim and Zealand Pharma A/S (Nasdaq: ZEAL) today announced additional data demonstrating superior efficacy with survodutide (also known as BI 456906) versus placebo in people...

Basildon, June 23, 2023 CNH Industrial N.V. (NYSE: CNHI / MI: CNHI) announces that it has completed the fourth $50 million tranche (the “Fourth Tranche”) of its $300 million common share buyback program. The Company completed transactions in the period June 14, 2023 to June 19, 2023, reported in aggregate as set forth in the table below. After the purchases announced today and considering those previously executed under the Fourth Tranche, the total invested amount is approximately €46,391,433.70 ($49,999,997.21) for a total amount of 3,678,065 common shares purchased.Date Number of common shares purchased Average priceper shareexcluding fees Considerationexcluding fees Consideration (*)excluding fees    (€) (€) ($)June 14, 2023 16,779 13.2339 222,051.61 240,015.58June 15, 2023 186,000 13.3301 2,479,398.60 2,682,461.35June...

         ERYTECH announces the approval of the merger with Pherecydes and reports the results of the Combined Shareholder’s Meeting held on June 23, 2023All resolutions voted with a large majority according to Board of Directors recommendations Company renamed Phaxiam Therapeutics, creating a world leader in phage therapy          Lyon (France), June 23, 2023 – ERYTECH Pharma (Euronext Paris & Nasdaq: ERYP) announced today that all resolutions for which the Board of Directors recommended a vote in favor, including the approval of the merger with Pherecydes, were adopted by its shareholders at the Combined General Meeting that was held today, June 23, 2023 The adopted resolutions include:Approval of the annual financial statements and consolidated financial statements for the year ended December 31, 2022; Allocation of the...